Target intelligence / Profile preview

novel transcript, antisense to CDS2 (ENSG00000299247)

Target
ENSG00000299247
Molecular classification
Other, long non-coding RNA, antisense transcript
01

Overview

ENSG00000299247 is annotated as a novel RNA transcript on the antisense strand of the protein-coding gene CDS2. No protein product is currently annotated and no regulatory, pathological, or molecular function is described in curated databases[1]. Such antisense transcripts are sometimes involved in the regulation of their corresponding sense gene, but there is no evidence for a characterized function for this particular transcript. This entry is not considered a classical therapeutic target such as a receptor, enzyme, transporter, or disease marker, and may represent a transcript discovered computationally that is yet unvalidated or functionally undefined in the literature[1][4][7].\n\nKey points:\n- This entry does not refer to a protein, receptor, enzyme, or druggable target.\n- There is no clinical or preclinical evidence for its use as a therapeutic biomarker, nor any interacting drugs or safety considerations.\n- Its annotation as \"novel transcript, antisense to CDS2\" indicates uncharacterized function, limited biological understanding, and a non-target status.\n- Antisense RNAs can regulate gene expression epigenetically or by RNA interference, but there is no evidence this transcript has such a function in the current literature[7].

Other names
novel transcript, antisense to CDS2
02

Biological functions

Unknown/Otherpossible regulatory RNA
03

Disease associations

Other or nullno established disease associationnot described in disease contexts

Beyond the preview

Go deeper on novel transcript, antisense to CDS2 (ENSG00000299247).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to CDS2 (ENSG00000299247).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call